Cognitive training in Parkinson disease: A systematic review and meta-analysis

Isabella H K Leung, Courtney C Walton, Harry Hallock, Simon J G Lewis, Michael Valenzuela, Amit Lampit, Isabella H K Leung, Courtney C Walton, Harry Hallock, Simon J G Lewis, Michael Valenzuela, Amit Lampit

Abstract

Objective: To quantify the effects of cognitive training (CT) on cognitive and behavioral outcome measures in patients with Parkinson disease (PD).

Methods: We systematically searched 5 databases for randomized controlled trials (RCTs) of CT in patients with PD reporting cognitive or behavioral outcomes. Efficacy was measured as standardized mean difference (Hedges g) of post-training change.

Results: Seven studies encompassing 272 patients with Hoehn & Yahr Stages 1-3 were included. The overall effect of CT over and above control conditions was small but statistically significant (7 studies: g = 0.23, 95% confidence interval [CI] 0.014-0.44, p = 0.037). True heterogeneity across studies was low (I(2) = 0%) and there was no evidence of publication bias. Larger effect sizes were noted on working memory (4 studies: g = 0.74, CI 0.32-1.17, p = 0.001), processing speed (4 studies: g = 0.31, CI 0.01-0.61, p = 0.04), and executive function (5 studies: g = 0.30, CI 0.01-0.58, p = 0.042), while effects on measures of global cognition (4 studies), memory (5 studies), visuospatial skills (4 studies), and depression (5 studies), as well as attention, quality of life, and instrumental activities of daily living (3 studies each), were not statistically significant. No adverse events were reported.

Conclusions: Though still small, the current body of RCT evidence indicates that CT is safe and modestly effective on cognition in patients with mild to moderate PD. Larger RCTs are necessary to examine the utility of CT for secondary prevention of cognitive decline in this population.

© 2015 American Academy of Neurology.

Figures

Figure 1. Summary of trial identification and…
Figure 1. Summary of trial identification and selection
Note that a single study could be excluded on more than one criterion, but appears only once in the chart. RCT = randomized controlled trial.
Figure 2. Overall efficacy of cognitive training…
Figure 2. Overall efficacy of cognitive training on all cognitive outcomes
Effect estimates are based on a random-effects model. CI = confidence interval; CT = cognitive training.
Figure 3. Efficacy of cognitive training on…
Figure 3. Efficacy of cognitive training on measures of executive function, processing speed, working memory, and global cognition
Effect estimates are based on a random-effects model. CI = confidence interval; CT = cognitive training.
Figure 4. Efficacy of cognitive training on…
Figure 4. Efficacy of cognitive training on measures of attention, memory, visuospatial skills, and depression
Effect estimates are based on a random-effects model. CI = confidence interval; CT = cognitive training.

References

    1. Burn D, Weintraub D, Robbins T. Introduction: the importance of cognition in movement disorders. Mov Disord 2014;29:581–583.
    1. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord 2012;27:349–356.
    1. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689–1707.
    1. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012;11:697–707.
    1. Seppi K, Weintraub D, Coelho M, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011;26(suppl 3):S42–S80.
    1. Mowszowski L, Batchelor J, Naismith SL. Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? Int Psychogeriatr 2010;22:537–548.
    1. Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med 2014;11:e1001756.
    1. Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature. Am J Geriatr Psychiatry 2015;23:335–359.
    1. Walton CC, Shine JM, Mowszowski L, Naismith SL, Lewis SJ. Freezing of gait in Parkinson's disease: current treatments and the potential role for cognitive training. Restor Neurol Neurosci 2014;32:411–422.
    1. Hindle JV, Petrelli A, Clare L, Kalbe E. Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review. Mov Disord 2013;28:1034–1049.
    1. Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis 2012;2012:512892.
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
    1. Strauss EH, Sherman EMS, Spreen OA, editors. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. Oxford: Oxford University Press; 2006.
    1. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley Online Library; 2008.
    1. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003;83:713–721.
    1. Borenstein M, Hedges L, Higgins JP, Rothstein HR. Introduction to Meta-analysis. Chichester: Wiley; 2009.
    1. Gleser LJ, Olkin I. Stochastically dependent effect sizes. In: Cooper H, Hedges L, Valentine J, editors. The Handbook of Research Synthesis and Meta-analysis, 2nd ed New York: Russell Sage Foundation; 2009:357–376.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
    1. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
    1. Cerasa A, Gioia MC, Salsone M, et al. Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci 2014;35:1173–1180.
    1. Edwards JD, Hauser RA, O'Connor ML, Valdes EG, Zesiewicz TA, Uc EY. Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology 2013;81:1284–1290.
    1. Pena J, Ibarretxe-Bilbao N, Garcia-Gorostiaga I, Gomez-Beldarrain MA, Diez-Cirarda M, Ojeda N. Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 2014;83:2167–2174.
    1. Paris AP, Saleta HG, de la Cruz Crespo Maraver M, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Mov Disord 2011;26:1251–1258.
    1. Petrelli A, Kaesberg S, Barbe MT, et al. Effects of cognitive training in Parkinson's disease: a randomized controlled trial. Parkinsonism Relat Disord 2014;20:1196–1202.
    1. Pompeu JE, Mendes FA, Silva KG, et al. Effect of Nintendo Wii-based motor and cognitive training on activities of daily living in patients with Parkinson's disease: a randomised clinical trial. Physiotherapy 2012;98:196–204.
    1. Sammer G, Reuter I, Hullmann K, Kaps M, Vaitl D. Training of executive functions in Parkinson's disease. J Neurol Sci 2006;248:115–119.
    1. Zimmermann R, Gschwandtner U, Benz N, et al. Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training. Neurology 2014;82:1219–1226.
    1. Burdick DJ, Cholerton B, Watson GS, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 2014;29:1258–1264.
    1. Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351–6356.
    1. Robbins TW, Cools R. Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective. Mov Disord 2014;29:597–607.
    1. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9:1200–1213.
    1. Karayanidis F. Parkinson's disease: a conceptualization of neuropsychological deficits within an information-processing framework. Biol Psychol 1989;29:149–179.
    1. Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991;41:365–369.
    1. Naismith SL, Mowszowski L, Diamond K, Lewis SJ. Improving memory in Parkinson's disease: a healthy brain ageing cognitive training program. Mov Disord 2013;28:1097–1103.
    1. Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol 2011;2:82.
    1. Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. J Aging Res 2012;2012:235765.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit